Maximum quantity allowed is 999
CAS RN: 202590-98-5 | Product Number: O0482
OTX 015

Purity: >98.0%(HPLC)
- 2-[(6S)-4-(4-Chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)acetamide
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
10MG |
₹7,400.00
|
Contact Us | 10 |
|
50MG |
₹29,000.00
|
Contact Us | 21 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | O0482 |
Purity / Analysis Method ![]() |
>98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__5H__2__2ClN__5O__2S = 491.99 |
Physical State (20 deg.C) | Solid |
Storage Temperature ![]() |
Frozen (<0°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 202590-98-5 |
Reaxys Registry Number | 13264398 |
PubChem Substance ID | 468592525 |
MDL Number | MFCD26960949 |
Appearance | White to Light yellow to Light orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Elemental analysis(Nitrogen) | 13.50 to 15.00 % |
NMR | confirm to structure |
Melting Point | 220 °C |
References
- 1) Bromodomains: a new target class for drug development
- 2) The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs
- 3) Abstract C244: Development of the BET bromodomain inhibitor OTX015.
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.